Dumas Jacques
Insider CIK 1598640 · IDIX EVP, Chief Scientific Officer · TTPH Chief ScientificOfficer
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| TTPH TETRAPHASE PHARMACEUTICALS | A Award deriv | 2019-01-17 | 2019-01-18 | 140,000 | — | $0 | 140,000 | SEC↗ |
| TTPH TETRAPHASE PHARMACEUTICALS | A Award deriv | 2019-01-17 | 2019-01-18 | 40,000 | — | $0 | 40,000 | SEC↗ |
| TTPH TETRAPHASE PHARMACEUTICALS | S Sale | 2019-01-08 | 2019-01-10 | 7,497 | $1.60 | $12.0K | 0 | SEC↗ |
| TTPH TETRAPHASE PHARMACEUTICALS | A Award deriv | 2018-04-02 | 2018-04-04 | 40,000 | — | $0 | 40,000 | SEC↗ |
| TTPH TETRAPHASE PHARMACEUTICALS | M Exercise deriv | 2018-01-30 | 2018-01-31 | 8,750 | — | $0 | 105,000 | SEC↗ |
| TTPH TETRAPHASE PHARMACEUTICALS | S Sale | 2018-01-30 | 2018-01-31 | 8,750 | $6.22 | $54.4K | 0 | SEC↗ |
| TTPH TETRAPHASE PHARMACEUTICALS | M Exercise | 2018-01-30 | 2018-01-31 | 8,750 | $3.69 | $32.3K | 8,750 | SEC↗ |
| TTPH TETRAPHASE PHARMACEUTICALS | A Award deriv | 2018-01-17 | 2018-01-19 | 140,000 | — | $0 | 140,000 | SEC↗ |
| TTPH TETRAPHASE PHARMACEUTICALS | A Award deriv | 2018-01-17 | 2018-01-19 | 40,000 | — | $0 | 40,000 | SEC↗ |
| TTPH TETRAPHASE PHARMACEUTICALS | S Sale | 2018-01-09 | 2018-01-11 | 7,167 | $6.21 | $44.5K | 0 | SEC↗ |
| TTPH TETRAPHASE PHARMACEUTICALS | M Exercise deriv | 2017-10-31 | 2017-11-02 | 8,750 | — | $0 | 113,750 | SEC↗ |
| TTPH TETRAPHASE PHARMACEUTICALS | M Exercise | 2017-10-31 | 2017-11-02 | 8,750 | $3.69 | $32.3K | 8,750 | SEC↗ |
| TTPH TETRAPHASE PHARMACEUTICALS | S Sale | 2017-10-31 | 2017-11-02 | 8,750 | $6.03 | $52.8K | 0 | SEC↗ |
| TTPH TETRAPHASE PHARMACEUTICALS | M Exercise deriv | 2017-08-22 | 2017-08-24 | 17,500 | — | $0 | 122,500 | SEC↗ |
| TTPH TETRAPHASE PHARMACEUTICALS | M Exercise | 2017-08-22 | 2017-08-24 | 17,500 | $3.69 | $64.6K | 17,500 | SEC↗ |
| TTPH TETRAPHASE PHARMACEUTICALS | S Sale | 2017-08-22 | 2017-08-24 | 17,500 | $6.00 | $105.0K | 0 | SEC↗ |
| TTPH TETRAPHASE PHARMACEUTICALS | S Sale | 2017-08-17 | 2017-08-21 | 7,155 | $5.86 | $41.9K | 0 | SEC↗ |
| TTPH TETRAPHASE PHARMACEUTICALS | A Award deriv | 2017-01-31 | 2017-02-01 | 30,000 | — | $0 | 30,000 | SEC↗ |
| TTPH TETRAPHASE PHARMACEUTICALS | A Award deriv | 2017-01-30 | 2017-02-01 | 140,000 | — | $0 | 140,000 | SEC↗ |
| IDIX IDENIX PHARMACEUTICALS INC | D To issuer deriv | 2014-08-05 | 2014-08-05 | 250,000 | — | $0 | 0 | SEC↗ |